{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:02:19Z","timestamp":1790686939988,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board, Ireland","doi-asserted-by":"publisher","award":["HPF -2015-977"],"award-info":[{"award-number":["HPF -2015-977"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.pan.2019.07.039","type":"journal-article","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T11:40:48Z","timestamp":1563968448000},"page":"850-857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2326-3009","authenticated-orcid":false,"given":"Oonagh M.","family":"Griffin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinead N.","family":"Duggan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Geoghegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Conlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pan.2019.07.039_bib1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12029-015-9724-1","article-title":"A\u00a0systematic review of the burden of pancreatic cancer in Europe: real-world impact on survival, quality of life and costs","volume":"46","author":"Carrato","year":"2015","journal-title":"J\u00a0Gastrointest Cancer"},{"issue":"1","key":"10.1016\/j.pan.2019.07.039_bib2","first-page":"7","article-title":"Cancer Statistics, 2018","volume":"68","author":"Siegal","year":"2018","journal-title":"CA A Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.pan.2019.07.039_bib3","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.6004\/jnccn.2017.0131","article-title":"Pancreatic adenocarcinoma, version 2.2017, NCCN clinical practice guidelines in oncology","volume":"15","author":"Tempero","year":"2017","journal-title":"J\u00a0Natl Compr Cancer Netw"},{"issue":"3","key":"10.1016\/j.pan.2019.07.039_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/nu9030243","article-title":"Nutritional and metabolic derangements in pancreatic cancer and pancreatic resection","volume":"9","author":"Gilliland","year":"2017","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.pan.2019.07.039_bib5","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s11605-008-0505-z","article-title":"Cachexia worsens prognosis in patients with resectable pancreatic cancer","volume":"12","author":"Bachmann","year":"2008","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"22","key":"10.1016\/j.pan.2019.07.039_bib6","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1158\/1078-0432.CCR-09-1525","article-title":"Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer","volume":"15","author":"Tan","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10.1016\/j.pan.2019.07.039_bib7","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.pan.2019.07.039_bib8","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.pan.2019.07.039_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.pan.2014.11.006","article-title":"Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review","volume":"15","author":"Ozola Zalite","year":"2015","journal-title":"Pancreatology"},{"issue":"12","key":"10.1016\/j.pan.2019.07.039_bib10","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/bjs.9893","article-title":"Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignancies","volume":"102","author":"Levolger","year":"2015","journal-title":"Br J Surg"},{"issue":"5","key":"10.1016\/j.pan.2019.07.039_bib11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.pan.2019.07.039_bib12","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1139\/H08-075","article-title":"A\u00a0practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care","volume":"33","author":"Mourtzakis","year":"2008","journal-title":"Appl Physiol Nutr Metabol"},{"issue":"6","key":"10.1016\/j.pan.2019.07.039_bib13","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1152\/japplphysiol.00744.2004","article-title":"Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image","volume":"97","author":"Shen","year":"2004","journal-title":"J\u00a0Appl Physiol (1985)"},{"issue":"2","key":"10.1016\/j.pan.2019.07.039_bib14","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1017\/S0007114512001067","article-title":"Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia","volume":"109","author":"Di Sebastiano","year":"2013","journal-title":"Br J Nutr"},{"issue":"7711","key":"10.1016\/j.pan.2019.07.039_bib15","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41586-018-0235-7","article-title":"Altered exocrine function can drive adipose wasting in early pancreatic cancer","volume":"558","author":"Danai","year":"2018","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.pan.2019.07.039_bib16","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1007\/s00268-015-3205-3","article-title":"Prognostic significance of muscle attenuation in pancreatic cancer patients treated with neoadjuvant chemoradiotherapy","volume":"39","author":"Akahori","year":"2015","journal-title":"World J Surg"},{"issue":"6","key":"10.1016\/j.pan.2019.07.039_bib17","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1152\/jappl.2001.90.6.2157","article-title":"Attenuation of skeletal muscle and strength in the elderly: the Health ABC Study","volume":"90","author":"Goodpaster","year":"2001","journal-title":"J\u00a0Appl Physiol (1985)"},{"issue":"2","key":"10.1016\/j.pan.2019.07.039_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s13539-011-0030-x","article-title":"Intramyocellular lipid droplets increase with progression of cachexia in cancer patients","volume":"2","author":"Stephens","year":"2011","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"5","key":"10.1016\/j.pan.2019.07.039_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196235","article-title":"Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas","volume":"13","author":"Stretch","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.pan.2019.07.039_bib20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jcsm.12155","article-title":"Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic cancer","volume":"8","author":"van Dijk","year":"2017","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"7","key":"10.1016\/j.pan.2019.07.039_bib21","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1245\/s10434-014-4285-2","article-title":"Characterization of anthropometric changes that occur during neoadjuvant therapy for potentially resectable pancreatic cancer","volume":"22","author":"Cooper","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.pan.2019.07.039_bib22","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s11605-017-3618-4","article-title":"Anthropometric changes in patients with pancreatic cancer undergoing preoperative therapy and pancreatoduodenectomy","volume":"22","author":"Cloyd","year":"2018","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"9","key":"10.1016\/j.pan.2019.07.039_bib23","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/jamasurg.2018.0979","article-title":"Association between changes in body composition and neoadjuvant treatment for pancreatic cancer","volume":"153","author":"Sandini","year":"2018","journal-title":"JAMA Surg"},{"issue":"6","key":"10.1016\/j.pan.2019.07.039_bib24","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/cam4.1071","article-title":"Neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of prospective studies","volume":"6","author":"Zhan","year":"2017","journal-title":"Cancer Med"},{"issue":"2","key":"10.1016\/j.pan.2019.07.039_bib25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/jcsm.12267","article-title":"Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer","volume":"9","author":"Daly","year":"2018","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"9","key":"10.1016\/j.pan.2019.07.039_bib27","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/annonc\/mdx271","article-title":"Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy","volume":"28","author":"Bozzetti","year":"2017","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.pan.2019.07.039_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","article-title":"ESPEN guidelines on nutrition in cancer patients","volume":"36","author":"Arends","year":"2017","journal-title":"Clin Nutr"},{"issue":"7592","key":"10.1016\/j.pan.2019.07.039_bib29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature16965","article-title":"Genomic analyses identify molecular subtypes of pancreatic cancer","volume":"531","author":"Bailey","year":"2016","journal-title":"Nature"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390319306702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390319306702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:33:08Z","timestamp":1790685188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390319306702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1424390319306702"],"URL":"https:\/\/doi.org\/10.1016\/j.pan.2019.07.039","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Pancreatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pan.2019.07.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 IAP and EPC. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}